RDHL
Redhill Biopharma
RDHL
RDHL
8 hedge funds and large institutions have $15.9M invested in Redhill Biopharma in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
MMG
1
Monetary Management Group
St Louis,
Missouri
|
$77K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$17K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$16K |
Top Sellers
| 1 |
SFM
1
Sphera Funds Management
Tel Aviv,
Israel
|
$0 |
| 2 |
O
2
OrbiMed
New York
|
$10.6M |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$0 |
| 4 |
4
Citigroup
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $10.6M | 605,800 | -25,780 | -4% |
|
|
BC
2
Broadfin Capital
New York
| $4.6M | 263,160 | – | – |
|
3
Goldman Sachs
New York
| $507K | 29,000 | – | – |
|
|
MMG
4
Monetary Management Group
St Louis,
Missouri
| $77K | 4,400 | +4,400 | New |
|
5
Wells Fargo
San Francisco,
California
| $52K | 3,000 | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $17K | 1,000 | +1,000 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $16K | 927 | +132 | +17% |
|
|
SFM
8
Sphera Funds Management
Tel Aviv,
Israel
| – | – | -1,714,880 | Closed |
|
|
U
9
UBS
Zurich,
Switzerland
| – | – | -300 | Closed |
|
|
10
Citigroup
New York
| – | – | -100 | Closed |
|
11
Morgan Stanley
New York
| $0 | 4 | +2 | +100% |
|